Altretamine
- CAS No.
- 645-05-6
- Chemical Name:
- Altretamine
- Synonyms
- HMM;HTM;Hemel;NC 195;Hexylen;Hexalen;RB-1515;ent50852;Hexastat;nsc13875
- CBNumber:
- CB9480937
- Molecular Formula:
- C9H18N6
- Molecular Weight:
- 210.28
- MOL File:
- 645-05-6.mol
- MSDS File:
- SDS
- Modify Date:
- 2023/9/11 16:43:46
| Melting point | 171-175 °C (lit.) |
|---|---|
| Boiling point | 339.81°C (rough estimate) |
| Density | 1.0441 (rough estimate) |
| refractive index | 1.6100 (estimate) |
| storage temp. | Keep in dark place,Inert atmosphere,Room temperature |
| solubility | Chloroform (Sparingly), Methanol (Slightly, Heated) |
| form | solid |
| pka | pKa 10.3 (Uncertain) |
| color | White to Off-White |
| Water Solubility | Insoluble |
| Merck | 13,318 |
| CAS DataBase Reference | 645-05-6(CAS DataBase Reference) |
| NIST Chemistry Reference | Altretamine(645-05-6) |
| EPA Substance Registry System | Altretamine (645-05-6) |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |  GHS07 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Warning | |||||||||
| Hazard statements | H302-H315-H319-H335 | |||||||||
| Precautionary statements | P261-P264-P270-P301+P312-P302+P352-P305+P351+P338 | |||||||||
| Hazard Codes | Xn | |||||||||
| Risk Statements | 22-36/37/38 | |||||||||
| Safety Statements | 26-36 | |||||||||
| WGK Germany | 3 | |||||||||
| RTECS | OS1050000 | |||||||||
| HS Code | 2933690000 | |||||||||
| Toxicity | LD50 in rats, guinea pigs (mg/kg): 350, 255 orally (Jasper) | |||||||||
| NFPA 704 |
|
Altretamine price More Price(2)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich(India) | PHR2343 | Altretamine Pharmaceutical Secondary Standard; Certified Reference Material | 645-05-6 | 1G | ₹16508.13 | 2022-06-14 | Buy |
| Sigma-Aldrich(India) | 549835 | 2,4,6-Tris(dimethylamino)-1,3,5-triazine 96% | 645-05-6 | 25G | ₹28090.88 | 2022-06-14 | Buy |
Altretamine Chemical Properties,Uses,Production
Chemical Properties
White Solid
Uses
An antitumor agent which also acts as a chemosterilant for male houseflies and other insects. Antineoplastic.
Indications
Although both DNA and RNA synthesis are inhibited in cells exposed to hexamethylmelamine (Hexalen), the molecular mechanisms of these effects are not known.
Definition
A hexamethyl-2,4,6- triamine derivative of 1,3,5-triazine.
General Description
Altretamine is available in 50-mg capsules for oraladministration as a second-line treatment for ovarian cancer.The mechanism of action has not been firmly established, althoughthe spectrum of activity is similar to that for otheralkylating agents; however, cross-resistance is not seen.Cytotoxicity has been correlated with metabolism to give thecarbinolamines, which may form imines capable of crosslinking,or decompose to give formaldehyde, which may reactwith nucleophiles on DNA or proteins. The agent is well absorbedupon oral administration, well distributed, and highly(90%) plasma protein bound. The agent is extensively metabolizedin the liver by CYP to give demethylated metabolites via the previously mentioned carbinolamines. Elimination occursprimarily in the urine as mostly demethylated metaboliteswith a terminal elimination half-life of 4 to 10 hours.Myleosuppression and nausea/vomiting are dose-limitingtoxicities. Other adverse effects include lethargy, agitation,hallucinations, skin rash, and elevations in transaminase levels,flulike symptoms, abdominal cramps, and diarrhea.
Air & Water Reactions
Insoluble in water.
Reactivity Profile
Altretamine neutralizes acids in exothermic reactions to form salts plus water. May be incompatible with isocyanates, halogenated organics, peroxides, phenols (acidic), epoxides, anhydrides, and acid halides. Flammable gaseous hydrogen may be generated in combination with strong reducing agents, such as hydrides.
Hazard
Toxic.
Mechanism of action
Hexamethylmelamine is readily absorbed after oral administration, with peak plasma levels achieved after 1 hour.The drug is readily metabolized to form a number of demethylated metabolites. Urinary elimination is the primary route of drug excretion.
Clinical Use
Hexamethylmelamine is useful for the treatment of ovarian adenocarcinoma and is frequently combined with cyclophosphamide, cisplatin, and doxorubicin in the treatment of this tumor. It also has some activity against small cell lung cancer.
Side effects
Nausea and vomiting are the major toxicities associated with hexamethylmelamine administration. Myelosuppression and a peripheral neuropathy also may occur.
Metabolism
This unique structure is believed to damage tumor cells through the production of the weakly alkylating species formaldehyde, a product of CYP450-mediated N-demethylation. Administered orally, altretamine is extensively metabolized on first pass, producing primarily mono- and didemethylated metabolites. Additional demethylation reactions occur in tumor cells, releasing formaldehyde in situ before the drug is excreted in the urine.
Altretamine Preparation Products And Raw materials
Raw materials
Preparation Products
| Supplier | Tel | Country | ProdList | Advantage | Inquiry |
|---|---|---|---|---|---|
| Pharmaffiliates Analytics and Synthetics P. Ltd | +91-172-5066494 | Haryana, India | 6773 | 58 | Inquiry |
| A.J Chemicals | 91-9810153283 | New Delhi, India | 6124 | 58 | Inquiry |
| CLEARSYNTH LABS LTD. | +91-22-45045900 | Hyderabad, India | 6351 | 58 | Inquiry |
| Pharma Affiliates | 172-5066494 | Haryana, India | 6761 | 58 | Inquiry |
| Ayon PharmaChem | 91-22-28638348 | Maharashtra, India | 303 | 58 | Inquiry |
| Hebei Mojin Biotechnology Co., Ltd | +8613288715578 | China | 12452 | 58 | Inquiry |
| Henan Tianfu Chemical Co.,Ltd. | +86-0371-55170693 +86-19937530512 | China | 21669 | 55 | Inquiry |
| career henan chemical co | +86-0371-86658258 +8613203830695 | China | 29896 | 58 | Inquiry |
| Hebei Guanlang Biotechnology Co., Ltd. | +86-19930503282 | China | 8822 | 58 | Inquiry |
| Chongqing Chemdad Co., Ltd | +86-023-6139-8061 +86-86-13650506873 | China | 39916 | 58 | Inquiry |
645-05-6(Altretamine)Related Search:
1of4
chevron_right